Market Overview Hurthle Cell Carcinoma Treatment Market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2031 growing with a CAGR of 6% during the forecast period 2024-2031. The Hurthle Cell Carcinoma (HCC) Market covering diagnostics, surgical care, radioactive iodine (where applicable), systemic therapies and follow-on supportive treatments is expanding...